PsychedelicWire's profile picture. All the fast-moving companies, hot news and info about breakthroughs in psychedelic therapeutics and mushrooms as medicine. Full disclaimers: http://bit.ly/2CkJK9T

PsychedelicNewsWire

@PsychedelicWire

All the fast-moving companies, hot news and info about breakthroughs in psychedelic therapeutics and mushrooms as medicine. Full disclaimers: http://bit.ly/2CkJK9T

PsychedelicNewsBreaks – $NRXP Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100 ibn.fm/99I0U

PsychedelicWire's tweet image. PsychedelicNewsBreaks – $NRXP Licenses Real-World Evidence From 70,000 Patients to Support FDA Accelerated Approval of NRX-100 ibn.fm/99I0U

PsychedelicNewsBreaks – $NRXP Eliminates Balance Sheet Debt Through Anson Equity Conversion ibn.fm/3pGa7

PsychedelicWire's tweet image. PsychedelicNewsBreaks – $NRXP Eliminates Balance Sheet Debt Through Anson Equity Conversion ibn.fm/3pGa7

PsychedelicNewsBreaks – $NRXP to Present at NobleCon21 ibn.fm/e5zzh

PsychedelicWire's tweet image. PsychedelicNewsBreaks – $NRXP to Present at NobleCon21 ibn.fm/e5zzh

$NRXP Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies ibn.fm/yf9lo

PsychedelicWire's tweet image. $NRXP Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies ibn.fm/yf9lo

MissionIRNewsBreaks – $NRXP Advances KETAFREE(TM), Expands Pipeline Targeting Urgent Needs ibn.fm/szbeZ

PsychedelicWire's tweet image. MissionIRNewsBreaks – $NRXP Advances KETAFREE(TM), Expands Pipeline Targeting Urgent Needs ibn.fm/szbeZ

$NRXP Gains FDA Nod for Preservative-Free Ketamine Suitability Petition ibn.fm/Lk3aZ

PsychedelicWire's tweet image. $NRXP Gains FDA Nod for Preservative-Free Ketamine Suitability Petition ibn.fm/Lk3aZ

PsychedelicNewsBreaks – $NRXP Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical ibn.fm/DXSB6

PsychedelicWire's tweet image. PsychedelicNewsBreaks – $NRXP Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical ibn.fm/DXSB6

$NRXP Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression ibn.fm/xZyvl

PsychedelicWire's tweet image. $NRXP Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression ibn.fm/xZyvl

PsychedelicNewsBreaks – $NRXP Showcases HOPE Therapeutics at Global Passion Project Event ibn.fm/54Qz9

PsychedelicWire's tweet image. PsychedelicNewsBreaks – $NRXP Showcases HOPE Therapeutics at Global Passion Project Event ibn.fm/54Qz9

$NRXP Seeks FDA Ban on Toxic Ketamine Preservative ibn.fm/Pm9Jo

PsychedelicWire's tweet image. $NRXP Seeks FDA Ban on Toxic Ketamine Preservative ibn.fm/Pm9Jo

PsychedelicNewsBreaks – $NRXP Subsidiary HOPE Therapeutics(TM) Secures Florida Regulatory Clearance to Close Dura Medical Acquisition ibn.fm/n4OIA

PsychedelicWire's tweet image. PsychedelicNewsBreaks – $NRXP Subsidiary HOPE Therapeutics(TM) Secures Florida Regulatory Clearance to Close Dura Medical Acquisition ibn.fm/n4OIA

PsychedelicNewsBreaks – $NRXP Positioning at the Forefront of Next-Gen Treatment ibn.fm/LCCpf

PsychedelicWire's tweet image. PsychedelicNewsBreaks – $NRXP Positioning at the Forefront of Next-Gen Treatment ibn.fm/LCCpf

$NRXP Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100 ibn.fm/IznWK

PsychedelicWire's tweet image. $NRXP Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100 ibn.fm/IznWK

PsychedelicNewsBreaks – $NRXP Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch ibn.fm/LOLSX

PsychedelicWire's tweet image. PsychedelicNewsBreaks – $NRXP Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch ibn.fm/LOLSX

PsychedelicNewsBreaks – $PBM to Present at Psychedelic Science 2025 ibn.fm/qr93E

PsychedelicWire's tweet image. PsychedelicNewsBreaks – $PBM to Present at Psychedelic Science 2025 ibn.fm/qr93E

$NRXP Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage ibn.fm/ji1Ro

PsychedelicWire's tweet image. $NRXP Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage ibn.fm/ji1Ro

$NRXP Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network ibn.fm/y0R4H

PsychedelicWire's tweet image. $NRXP Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network ibn.fm/y0R4H

PsychedelicNewsBreaks – $NRXP Files ANDA for Preservative-Free IV Ketamine, Targets Expanding $750M Market ibn.fm/wZGLJ

PsychedelicWire's tweet image. PsychedelicNewsBreaks – $NRXP Files ANDA for Preservative-Free IV Ketamine, Targets Expanding $750M Market ibn.fm/wZGLJ

$NRXP Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval ibn.fm/73Ru2

PsychedelicWire's tweet image. $NRXP Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval ibn.fm/73Ru2

Loading...

Something went wrong.


Something went wrong.